1. Thyroid hormone T4 mitigates traumatic brain injury in mice by dynamically remodeling cell type specific genes, pathways, and networks in hippocampus and frontal cortex
- Author
-
Zhang, Guanglin, Diamante, Graciel, Ahn, In Sook, Palafox-Sanchez, Victoria, Cheng, Jenny, Cheng, Michael, Ying, Zhe, Wang, Susanna Sue-Ming, Abuhanna, Kevin Daniel, Phi, Nguyen, Arneson, Douglas, Cely, Ingrid, Arellano, Kayla, Wang, Ning, Zhang, Shujing, Peng, Chao, Gomez-Pinilla, Fernando, and Yang, Xia
- Subjects
Medical Biochemistry and Metabolomics ,Biomedical and Clinical Sciences ,Neurosciences ,Human Genome ,Genetics ,Traumatic Head and Spine Injury ,Traumatic Brain Injury (TBI) ,Neurodegenerative ,Physical Injury - Accidents and Adverse Effects ,Acquired Cognitive Impairment ,Brain Disorders ,1.1 Normal biological development and functioning ,2.1 Biological and endogenous factors ,Neurological ,Mild traumatic brain injury ,Thyroxine ,Single cell RNA sequencing ,Genome-wide association study ,hippocampus ,Frontal cortex ,Biochemistry and Cell Biology ,Clinical Sciences ,Biochemistry & Molecular Biology ,Biochemistry and cell biology ,Medical biochemistry and metabolomics - Abstract
The complex pathology of mild traumatic brain injury (mTBI) is a main contributor to the difficulties in achieving a successful therapeutic regimen. Thyroxine (T4) administration has been shown to prevent the cognitive impairments induced by mTBI in mice but the mechanism is poorly understood. To understand the underlying mechanism, we carried out a single cell transcriptomic study to investigate the spatiotemporal effects of T4 on individual cell types in the hippocampus and frontal cortex at three post-injury stages in a mouse model of mTBI. We found that T4 treatment altered the proportions and transcriptomes of numerous cell types across tissues and timepoints, particularly oligodendrocytes, astrocytes, and microglia, which are crucial for injury repair. T4 also reversed the expression of mTBI-affected genes such as Ttr, mt-Rnr2, Ggn12, Malat1, Gnaq, and Myo3a, as well as numerous pathways such as cell/energy/iron metabolism, immune response, nervous system, and cytoskeleton-related pathways. Cell-type specific network modeling revealed that T4 mitigated select mTBI-perturbed dynamic shifts in subnetworks related to cell cycle, stress response, and RNA processing in oligodendrocytes. Cross cell-type ligand-receptor networks revealed the roles of App, Hmgb1, Fn1, and Tnf in mTBI, with the latter two ligands having been previously identified as TBI network hubs. mTBI and/or T4 signature genes were enriched for human genome-wide association study (GWAS) candidate genes for cognitive, psychiatric and neurodegenerative disorders related to mTBI. Our systems-level single cell analysis elucidated the temporal and spatial dynamic reprogramming of cell-type specific genes, pathways, and networks, as well as cell-cell communications as the mechanisms through which T4 mitigates cognitive dysfunction induced by mTBI.
- Published
- 2024